Skip to main content
. 2019 May 21;51(3-4):270–279. doi: 10.1080/07853890.2019.1614657

Figure 4.

Figure 4.

Observed and predicted 30-day mortality by the Society of Thoracic Surgeons (STS) score in patients who underwent transcatheter (TAVR) or surgical aortic valve replacement (SAVR) along the study period. P-values are from the linear-by-linear association test.